» Articles » PMID: 23797316

Racial/Ethnic and Regional Differences in the Prevalence of Inflammatory Bowel Disease in the United States

Overview
Journal Digestion
Specialty Gastroenterology
Date 2013 Jun 26
PMID 23797316
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The magnitude of racial/ethnic and regional differences in the prevalence of inflammatory bowel disease (IBD) in the United States remains largely unknown.

Aims: To estimate differences in the prevalence of IBD by race/ethnicity and region.

Methods: The Medical Expenditure Panel Survey, a nationally representative survey of US households and medical conditions, was used. A multivariate logistic model was used in statistical analysis.

Results: Among 202,468 individuals surveyed during 1996-2007, 316 were diagnosed with IBD (26 Blacks, 21 Hispanics, and 5 Asians). The prevalence of IBD was higher in Whites [Crohn's disease: 154; ulcerative colitis (UC): 89] than Blacks (Crohn's disease: 68; UC: 25), Hispanics (Crohn's disease: 15; UC: 35), and Asians (Crohn's: 45; UC: 40) (all p < 0.05, except for UC in Asians). The differences in Crohn's disease between Whites and minorities and the difference in UC between Whites and Blacks remained significant in multivariate analysis. In multivariate analysis, there was no regional difference in the prevalence of Crohn's disease, but the prevalence of UC was higher in the Northeast than the South (p < 0.05).

Conclusions: There were significant racial/ethnic differences in the prevalence of IBD in the USA. The underlying etiology of these differences warrants additional research.

Citing Articles

Higher Rates of Certain Autoimmune Diseases in Transgender and Gender Diverse Youth.

Logel S, Maru J, Whitehead J, Brady C, Walch A, Lasarev M Transgend Health. 2024; 9(3):197-204.

PMID: 39109261 PMC: 11299103. DOI: 10.1089/trgh.2022.0079.


Inpatient outcomes of inflammatory bowel disease in hospitalized patients with COVID-19: analysis of a nationally representative sample.

Aldiabat M, Alsakarneh S, Daniel T, Butt M, Jagdish B, Rock J Proc (Bayl Univ Med Cent). 2024; 37(2):239-247.

PMID: 38343460 PMC: 10857601. DOI: 10.1080/08998280.2024.2303402.


The Role of Oral Probiotics in Alleviating Inflammation, Symptom Relief, and Postoperative Recurrence and Their Side Effects in Adults With Crohn's Disease: A Systematic Review.

Banoth D, Wali M, Bekova K, Abdulla N, Gurugubelli S, Lin Y Cureus. 2024; 15(12):e50901.

PMID: 38259373 PMC: 10801111. DOI: 10.7759/cureus.50901.


Managing Pregnancy and Nursing Affecting African American Women with Inflammatory Bowel Disease: Clinical Outcomes and Parenthood.

MKoma A, Ware J, Nabaweesi R, Chirwa S Med Res Arch. 2023; 11(6).

PMID: 37492395 PMC: 10367541. DOI: 10.18103/mra.v11i6.3784.


Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, A By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis.

Bragg M, Breaux W, MKoma A Medicina (Kaunas). 2023; 59(7).

PMID: 37476546 PMC: 10358352. DOI: 10.3390/medicina59071254.